| Filed | Description | |
|---|---|---|
| 11/4/25 | 1.01 Material Agreement | → |
| 6/17/24 | 1.01 Material Agreement | → |
| 10/23/23 | 1.01 Material Agreement | → |
| 7/18/22 | 1.01 Material Agreement | → |
| 7/14/22 | 1.01 Material Agreement | → |
| 5/7/21 | 1.01 Material Agreement | → |
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need.